Concarlo Therapeutics Alternatives & Competitors

12 companies similar to Concarlo Therapeutics — Developing solutions for drug-resistant cancer

ORIC Pharmaceuticals Inc.

Overcoming Resistance In Cancer

119 Post-IPO Equity $408.00M

South San Francisco, Unit...

Biopharma Biotechnology +3

Senex Biotechnology. Inc.

Preventing Adaptive Drug Resistance and Cancer Metastasis

5 Debt Financing $600.00K

Biotechnology Health and Wellness +1

Flare Therapeutics

Trailblazing the path to drugging transcription factors to discover precision medicines fo...

62 Series B $205.00M

Cambridge, United States

Biopharma Biotechnology +2

Prescient Therapeutics

A clinical stage oncology company developing personalised medicine approaches to cancer; c...

14 Post-IPO Equity $3.00M

Australia

Biopharma Biotechnology +3

Track all Concarlo Therapeutics competitors

Get real-time alerts when any of these companies raise funding, hire, or show growth signals.

See how it works

HiberCell

Developing Novel Therapeutics to Prevent Cancer Relapse and Metastasis

25 $128.20M

New York, United States

Biotechnology Health Care

Radionetics Oncology

Discovering and developing novel radiotherapeutics for the treatment of cancer.

48 Series A $135.00M

San Diego, United States

Health Care Health and Wellness +1

Myosin Therapeutics Inc.

Developing next generation therapeutics targeting molecular motors

8 Seed $3.00M

Jupiter, United States

Biotechnology Health Care +1

Elpiscience Biopharmaceuticals

Elpiscience is a clinical-stage biopharmaceutical company focused on developing next-gener...

32 Series C $260.00M

Shanghai, China

Biopharma Biotechnology +2

iOnctura

Developing precision small molecules to combat hard-to-treat tumors.

28 Series B $118.37M

Geneve, Switzerland

Biotechnology Health Care +2

Bright Biologics

Developing bispecific antibody drug to improve cancer treatment.

Sunnyvale, United States

Biotechnology Health Care +1

Normunity

Biotech company creating a new class of precision immuno-oncology medicines that enable no...

19 Series A $65.00M

Biotechnology Health and Wellness

Celularity Inc.

A next-gen Biotech company creating off-the-shelf cellular medicines for Cancer, Infectiou...

171 Post-IPO Equity $400.00M

United States

Biotechnology Health Care +1

Frequently Asked Questions

Companies similar to Concarlo Therapeutics include ORIC Pharmaceuticals Inc., Senex Biotechnology. Inc., Flare Therapeutics, Prescient Therapeutics, HiberCell. They work in Biotechnology and Health Care.

Bounce Watch lists 12 companies that share Concarlo Therapeutics's industries and are closest to it in business tags, services, target customers, business model and size.

Founded in July 2016 and headquartered in Brooklyn, New York, Concarlo is a precision-medicine oncology company focused on diagnosing and treating cancer with an innovative approach to targeting a unique cellular pathway - p27Kip1. Concarlo's novel IpY therapeutic will be the first inhibitor to solve the CDK2 resistanc...

Don't just read about them. Follow them.

BounceWatch watches Concarlo Therapeutics and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.

See how it works

Explore Related

Concarlo Therapeutics Profile ORIC Pharmaceuticals Inc. Alternatives Senex Biotechnology. Inc. Alternatives Flare Therapeutics Alternatives All Companies All Signals Trend Reports

Compiled from the BounceWatch company index. The 12 companies listed here were last checked between 11 Sep 2024 and 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.